International Journal of Nephrology and Renovascular Disease is an international, peer-reviewed, open-access journal focusing on the pathophysiology of the kidney and vascular supply. Epidemiology, screening, diagnosis, and treatment interventions are covered as well as basic science, biochemical and immunological studies. In particular, emphasis will be given to:
Chronic kidney disease
Complications of renovascular disease
Imaging techniques
Renal hypertension
Renal cancer
Treatment including pharmacological and transplantation
Dialysis and treatment of complications of dialysis and renal disease
Quality of Life
Patient satisfaction and preference
Health economic evaluations
The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions.
The International Journal of Nephrology and Renovascular Disease will no longer consider meta-analyses for publication.
Journal metrics
Usage
65K annual downloads/views
Citation metrics
2.1 (2023) Impact Factor
Q2 Impact Factor Best Quartile
2.6 (2023) 5 year IF
3.9 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.868 (2023) SNIP
0.584 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Professor Pravin Singhal, Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center
Editorial Board:
Dr Gaetano Alfano, Nephrology, University Hospital of Modena, Italy
Dr Olurotimi Badero, Cardiac Renal & Vascular Associates, Jackson, MS, United States
Dr George Bayliss, Division of Kidney Diseases and Hypertension, Rhode Island Hospital and Alpert Medical School, Brown University, United States
Professor Guang-Yan Cai, Department of Nephrology, Chinese PLA General Hospital & Medical College of Chinese PLA, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China Mainland (PRC)
Professor Adamasco Cupisti, Department of Clinical and Experimental Medicine, University of Pisa, Italy
Dr Claudia D'Alessandro, Department of Clinical and Experimental Medicine, University of Pisa, Italy
Dr Caigan Du, Department of Urologic Sciences, University of British Columbia, Canada
Professor Belda Dursun, Nephrology, Pamukkale University Medical School, Turkey
Dr Narender Goel, Nephrology and Internal Medicine, New Jersey Kidney Care, United States
Prof. Dr. Xin Gu, Pathology, Louisiana State University Health Sciences Center at Shreveport, United States
Dr Mohamed Hassanein, Division of Nephrology and Hypertension, University of Mississippi Medical Center, United States
Dr Chi Chiu Mok, Department of Medicine, Tuen Mun Hospital, Hong Kong
Professor Luis Gabriel Navar, Physiology, Tulane University School of Medicine, United States
Dr Larry Weinrauch, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States
Abstracting and indexing
International Journal of Nephrology and Renovascular Disease is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
International Journal of Nephrology and Renovascular Disease is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})